Related Experiment Video
Updated: Jul 17, 2026

03:42
A Murine Model of Hyperlipidemia-Induced Heart Failure with Preserved Ejection Fraction
Published on: March 29, 2024
Elevated blood pressure in transgenic lipoatrophic mice and altered vascular function
Kumiko Takemori1, Yu-Jing Gao, Lili Ding
1Department of Pathology, Kinki University School of Medicine, Osaka-Sayama, Osaka, Japan.
Hypertension (Dallas, Tex. : 1979)
|January 4, 2007
Summary
Perivascular fat plays a crucial role in regulating vascular function and blood pressure. Its absence in lipoatrophic mice leads to elevated blood pressure due to enhanced vascular contractility and altered receptor expression.
Area of Science:
- Cardiovascular Biology
- Endocrinology
- Vascular Physiology
Background:
- Perivascular adipose tissue (PVAT) influences vascular tone and function.
- Lipoatrophy, a condition characterized by fat loss, can impact metabolic and cardiovascular health.
Purpose of the Study:
- To investigate the role of perivascular fat in the control of vascular function and blood pressure regulation.
- To elucidate the mechanisms underlying blood pressure elevation in lipoatrophic mice.
Main Methods:
- Utilized lipoatrophic A-ZIP/F1 transgenic mice and wild-type (WT) littermates.
- Assessed blood pressure, vascular contractility in response to various agonists (phenylephrine, serotonin, Angiotensin II).
- Analyzed expression of Angiotensin II receptors and investigated the role of a perivascular fat-derived relaxation factor.
Main Results:
- A-ZIP/F1 mice exhibited higher blood pressure compared to WT mice.
- The absence of perivascular fat in A-ZIP/F1 mice reduced the inhibitory effect on vascular contraction and impaired relaxation factor release.
- Vascular Angiotensin II type 1 receptor expression was upregulated in A-ZIP/F1 mice, contributing to enhanced contractile responses.
- Treatment with an Angiotensin II type 1 receptor antagonist normalized blood pressure in A-ZIP/F1 mice.
Conclusions:
- Perivascular fat absence enhances vascular contractility and contributes to hypertension in lipoatrophic mice.
- Upregulation of vascular Angiotensin II type 1 receptors is a key mechanism in this blood pressure elevation.
- Targeting Angiotensin II type 1 receptors may be a therapeutic strategy for hypertension associated with lipoatrophy.
